Clicky

Shandong Sito Bio-technology Co Ltd(300583)

Description: Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid hormones, intermediates, and derivatives. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, dexamethasone epoxy hydrolysate, progesterone intermediate, opener, tetraene, androstenedione, ketal, acid removal, 3-ketal, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.


Keywords: Drugs Organ Systems Hormones Pregnanes Neurosteroids Steroid Dexamethasone Progestogens Diketones Progesterone Betamethasone

Home Page: www.sitobiotech.com

Renxin industrial park
Heze,
China
Phone: 86 53 0226 3536


Officers

Name Title
Mr. Qi Mi Chairman & GM
Mr. Fuwen Li Chief Financial Officer
Ms. Qing Zhi Kong Deputy Gen. Mang.
Qingli Zeng Securities Representative

Exchange: SHE

Country: CN

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 53.4884
Price-to-Book MRQ: 1.6549
Price-to-Sales TTM: 2.3884
IPO Date:
Fiscal Year End: December
Full Time Employees: 1140
Back to stocks